Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse
about
Evaluation of a multiple sclerosis cluster among nurses in an inpatient oncology wardThe experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke componentsNew Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple SclerosisMolecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and diseaseNrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitisAcrolein-mediated conduction loss is partially restored by K⁺ channel blockersAcrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the ratAcrolein and asthma attack prevalence in a representative sample of the United States adult population 2000-2009.Structural and biochemical abnormalities in the absence of acute deficits in mild primary blast-induced head trauma.Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage.Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury.Molecular mechanisms of acrolein toxicity: relevance to human diseaseNanomedicine strategies for treatment of secondary spinal cord injury.Acute systemic accumulation of acrolein in mice by inhalation at a concentration similar to that in cigarette smokeAcrolein Exposure in U.S. Tobacco Smokers and Non-Tobacco Users: NHANES 2005-2006.Acrolein-mediated injury in nervous system trauma and diseasesIncreased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.Determination of urine 3-HPMA, a stable acrolein metabolite in a rat model of spinal cord injuryMitigation of sensory and motor deficits by acrolein scavenger phenelzine in a rat model of spinal cord contusive injuryNew insights in the pathogenesis of multiple sclerosis--role of acrolein in neuronal and myelin damage.Elevated axonal membrane permeability and its correlation with motor deficits in an animal model of multiple sclerosisAcrolein scavengers: reactivity, mechanism and impact on health.Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents.Materials approaches for modulating neural tissue responses to implanted microelectrodes through mechanical and biochemical means.Acrolein and neuro disorders.Acrolein induces myelin damage in mammalian spinal cord.Dimercaprol is an acrolein scavenger that mitigates acrolein-mediated PC-12 cells toxicity and reduces acrolein in rat following spinal cord injury.Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains.Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis.
P2860
Q23912471-3D297A3A-16B8-4999-B970-0032BAC35B64Q27346351-14CC005D-DA0E-4367-9589-53D6AE033224Q28072844-B7B47812-008A-442D-9CDC-A0313BAA3703Q28081607-4E7CBB3E-C6AD-47A8-A2EA-552429AEBC01Q28394597-9E887DF9-DC47-47E7-B3A8-9CC0D808F7F2Q28829557-2723FC40-43D5-4328-BA62-85610E4CAA29Q30573749-39AEB520-65F0-4836-9758-382129829181Q33590933-18FA4C00-32A4-4DCB-9919-79FC98C8BD53Q33645240-62FD2E90-535D-43FC-B5D1-C88C63D2DE5DQ34657926-CB75697B-C569-43D6-B3A7-388ABD4BD94FQ34888636-B34FC5B0-421D-49EB-A72D-A530184467B3Q35014415-CABAD49A-B3E6-4E2A-99C3-CF0012F3A959Q35063603-8559AB90-4AC5-493C-A9C1-C4AF5BF7F895Q35427617-13B8B35A-D656-40FE-8EA5-AC49E3B935ADQ36350853-8469B730-9944-49CC-8580-C0AF0A2D6668Q36452743-BE03974F-F8C4-4A74-BC78-43217CD1BFFEQ36750834-622846B9-9629-4B2E-B59E-657D9F8D8C08Q36873901-14CD2B71-A508-46BD-9DAF-CDAEB6578015Q37055956-E67F671D-941F-4721-9007-07C41E4E92D7Q37075227-BFF44D28-0100-4054-80A6-89B59277755DQ37291226-3BDC9712-27AC-4E1D-A911-D7AB312523C5Q37673506-CFF3114E-F00D-4B75-87D3-28E23346E291Q37895630-BEC0D7E3-9CAB-47C7-8ACD-312386402655Q37909259-75BF44CF-9BAF-42B8-9217-498771E6D90FQ38296578-ED78F50B-67A7-44E8-BB50-5A21790F6AB6Q42610508-300A7C48-B4BA-4D1C-82BA-1A18FE5D078BQ46641095-1571A77E-E5EF-4930-9581-953259BA5336Q48116579-63E32FFE-4762-4D3E-80CA-3FDDB233BE0CQ48920801-157604E2-46E2-4DBA-B34B-8162D4EA048CQ55497030-131BC355-6665-458D-921E-8AB4C2BA3020
P2860
Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@ast
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@en
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@nl
type
label
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@ast
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@en
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@nl
prefLabel
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@ast
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@en
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@nl
P2093
P2860
P3181
P1433
P1476
Anti-acrolein treatment improv ...... immune encephalomyelitis mouse
@en
P2093
P2860
P3181
P356
10.1016/J.NEUROSCIENCE.2010.11.018
P407
P577
2011-01-26T00:00:00Z